FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC, adding to the existing approved product license.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Hypertension
• Opioid Withdrawal

Drugs mentioned

• DURACLON (Clonidine hydrochloride)

Snippet

SUPPL AP for DURACLON (CLONIDINE HYDROCHLORIDE)